Upload
nguyennga
View
221
Download
0
Embed Size (px)
Citation preview
Product Catalog
Ranitidine 150 mg
Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montréal (QC), Canada H4P 2T4
Zantac is a registered trademark of GlaxoSmithKline
1
ZANTAC®
Strength DIN/NPN Format National Brand Reference Shelf Life
150 mg 02293471Blistered 8 countBlistered 24 countBottled 50 count
24 Months
ACTIVE INGREDIENTS: Each tablet contains: 150 mg of Ranitidine,
as Ranitidine Hydrochloride.
Colloidal Silicon Dioxide, Croscarmellose Sodium, Iron Oxide Red, Iron Oxide Yellow,Magnesium Stearate, Microcrystalline Cellulose, Polyvinyl Alcohol, Soy Lecithin, Talc,
Titanium Dioxide, Xanthan Gum
Medicinal Ingredient Non-Medicinal Ingredients
Unscheduled for adult use. In package sizes containing
no more than 4,500 mg. Schedule III if over
4,500 mg
Unscheduled for adult use. In package sizes containing
no more than 4,500 mg. Schedule III if over
4,500 mg
Unscheduled for adult use. In package sizes containing
no more than 4,500 mg. Schedule III if over
4,500 mg
Unscheduled for adult use. In package sizes containing
no more than 4,500 mg. Schedule III if over
4,500 mg
Unscheduled for adult use. In package sizes containing
no more than 4,500 mg. Schedule III if over
4,500 mg
Unscheduled for adult use. In package sizes containing
no more than 4,500 mg. Schedule III if over
4,500 mg
NWT (Follows Napra National)
BC Alberta Manitoba (Follows Napra National)
Saskatchewan (Follows Napra National)
Ontario (Follows Napra National)
Quebec New Brunswick (Follows Napra National)
PEI (Follows Napra National)
Nova Scotia (Follows Napra National)
Nfld Yukon (Follows Napra National)
Annexe 3
Unscheduled for adult use. In package sizes containing
no more than 4,500 mg. Schedule III if over
4,500 mg
Unscheduled for adult use. In package sizes containing
no more than 4,500 mg. Schedule III if over
4,500 mg
Unscheduled for adult use. In package sizes containing
no more than 4,500 mg. Schedule III if over
4,500 mg
Unscheduled for adult use. In package sizes containing
no more than 4,500 mg. Schedule III if over
4,500 mg
Unscheduled for adult use. In package sizes containing
no more than 4,500 mg. Schedule III if over
4,500 mg
Product Catalog
Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montréal (QC), Canada H4P 2T4 2
Zantac is a registered trademark of GlaxoSmithKline
Strength DIN/NPN Format National Brand Reference Shelf Life
75 mg 02247551Blistered 10 countBlistered 30 count Blistered 60 count
24 Months
Medicinal Ingredient Non-Medicinal Ingredients
ACTIVE INGREDIENTS: Each tablet contains: 75 mg of Ranitidine,
as Ranitidine Hydrochloride.
Colloidal Silicon Dioxide, Iron Oxide Red, Magnesium Stearate, Microcrystalline Cellulose, Polyvinyl Alcohol, Sodium Croscarmellose, Soy Lecithin,
Talc, Titanium Dioxide, Xanthan Gum
Unscheduled in package sizes containing no more than 4,500 mg. Schedule
III if over 4,500 mg.
Unscheduled in package sizes containing no more than 4,500 mg. Schedule
III if over 4,500 mg.
Unscheduled in package sizes containing no more than 4,500 mg. Schedule
III if over 4,500 mg.
Unscheduled in package sizes containing no more than 4,500 mg. Schedule
III if over 4,500 mg.
Unscheduled in package sizes containing no more than 4,500 mg. Schedule
III if over 4,500 mg.
Unscheduled in package sizes containing no more than 4,500 mg. Schedule
III if over 4,500 mg.
Annexe 3
Unscheduled in package sizes containing no more than 4,500 mg. Schedule
III if over 4,500 mg.
Unscheduled in package sizes containing no more than 4,500 mg. Schedule
III if over 4,500 mg.
Unscheduled in package sizes containing no more than 4,500 mg. Schedule
III if over 4,500 mg.
Unscheduled in package sizes containing no more than 4,500 mg. Schedule
III if over 4,500 mg.
Unscheduled in package sizes containing no more than 4,500 mg. Schedule
III if over 4,500 mg.
Ranitidine 75 mg
ZANTAC®
NWT (Follows Napra National)
BC Alberta Manitoba (Follows Napra National)
Saskatchewan (Follows Napra National)
Ontario (Follows Napra National)
Quebec New Brunswick (Follows Napra National)
PEI (Follows Napra National)
Nova Scotia (Follows Napra National)
Nfld Yukon (Follows Napra National)
Product Catalog
Naproxen Sodium 220mg
Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montréal (QC), Canada H4P 2T4 3
ALEVE®
Aleve is a registered trademark of Bayer
Strength DIN/NPN Format National Brand Reference Shelf Life
220 mg 02362430
Bottled 24 countBottled 50 countBottled 100 countBottled 200 count
24 Months
Medicinal Ingredient Non-Medicinal Ingredients
ACTIVE INGREDIENTS: Each tablet contains:
220 mg Naproxen Sodium.
FD&C Blue No.2 Aluminum Lake, Hypromellose, Maize Starch, MicrocrystallineCellulose, Polyethylene Glycol, Povidone, Sodium Starch Glycolate, Stearic Acid,
Titanium Dioxide
When sold in products labeled with a recommended max daily dose of 440 mg:
Unscheduled for adult use. In package sizes of up to 6,600 mg. Schedule III in package sizes exceeding 6,600 mg
When sold in products labeled with a recommended max daily dose of 440 mg:
Unscheduled for adult use. In package sizes of up to 6,600 mg. Schedule III in package sizes exceeding 6,600 mg
When sold in products labeled with a recommended max daily dose of 440 mg:
Unscheduled for adult use. In package sizes of up to 6,600 mg. Schedule III in package sizes exceeding 6,600 mg
When sold in products labeled with a recommended max daily dose of 440 mg:
Unscheduled for adult use. In package sizes of up to 6,600 mg. Schedule III in package sizes exceeding 6,600 mg
When sold in products labeled with a recommended max daily dose of 440 mg:
Unscheduled for adult use. In package sizes of up to 6,600 mg. Schedule III in package sizes exceeding 6,600 mg
When sold in products labeled with a recommended max daily dose of 440 mg:
Unscheduled for adult use. In package sizes of up to 6,600 mg. Schedule III in package sizes exceeding 6,600 mg
Annexe 2
When sold in products labeled with a recommended max daily dose of 440 mg:
Unscheduled for adult use. In package sizes of up to 6,600 mg. Schedule III in package sizes exceeding 6,600 mg
When sold in products labeled with a recommended max daily dose of 440 mg:
Unscheduled for adult use. In package sizes of up to 6,600 mg. Schedule III in package sizes exceeding 6,600 mg
When sold in products labeled with a recommended max daily dose of 440 mg:
Unscheduled for adult use. In package sizes of up to 6,600 mg. Schedule III in package sizes exceeding 6,600 mg
When sold in products labeled with a recommended max daily dose of 440 mg: Schedule III in package sizes of up to 6,600 mg.
Schedule II in package sizes exceeding 6,600 mg
When sold in products labeled with a recommended max daily dose of 440 mg: Schedule III in package sizes of up to 6,600 mg.
Schedule II in package sizes exceeding 6,600 mg
NWT (Follows Napra National)
BC Alberta Manitoba (Follows Napra National)
Saskatchewan (Follows Napra National)
Ontario (Follows Napra National)
Quebec New Brunswick (Follows Napra National)
PEI (Follows Napra National)
Nova Scotia (Follows Napra National)
Nfld Yukon (Follows Napra National)
Product Catalog
Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montréal (QC), Canada H4P 2T4 4
Imodium is a registered trademark of McNeil consumer healthcare a division of Johnson & Johnson
Strength DIN/NPN Format National Brand Reference Shelf Life
2 mg 02248994
Blistered 6 count Blistered 12 count Blistered 24 count Blistered 42 count
48 Months
Medicinal Ingredient Non-Medicinal Ingredients
ACTIVE INGREDIENTS: Each tablet contains:
2 mg Loperamide hydrochloride.
Croscarmellose Sodium, D&C Yellow No. 10 Aluminum Lake,
FD&C Blue No. 1 Aluminum Lake, Lactose, Magnesium Stearate, Microcrystalline Cellulose and Povidone
Unscheduled for adult use.
Unscheduled for adult use.
Unscheduled for adult use.
Unscheduled for adult use.
Unscheduled for adult use.
Unscheduled for adult use.
Annexe 3Unscheduled for adult use.
Unscheduled for adult use.
Unscheduled for adult use.
Unscheduled for adult use.
Unscheduled for adult use.
Loperamide hydrochloride 2 mg
IMODIUM®
NWT (Follows Napra National)
BC Alberta Manitoba (Follows Napra National)
Saskatchewan (Follows Napra National)
Ontario (Follows Napra National)
Quebec New Brunswick (Follows Napra National)
PEI (Follows Napra National)
Nova Scotia (Follows Napra National)
Nfld Yukon (Follows Napra National)
Product Catalog
Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montréal (QC), Canada H4P 2T4 5
Aerius is a registered trademark of Schering
Strength DIN/NPN Format National Brand Reference Shelf Life
5 mg 02298155
Blistered 10 count Blistered 20 count Blistered 30 count Blistered 50 count
36 Months
Medicinal Ingredient Non-Medicinal Ingredients
ACTIVE INGREDIENTS: Each tablet contains: Desloratadine 5 mg.
FD&C Blue No. 2 Aluminum Lake, Hydroxypropyl Methylcellulose, Lactose,
Magnesium Oxide, Microcrystalline Cellulose, Polyethylene Glycol, Pregelatinized Corn Starch, Titanium Dioxide, Zinc Stearate
Unscheduled for adult use.
Unscheduled for adult use.
Unscheduled for adult use.
Unscheduled for adult use.
Unscheduled for adult use.
Unscheduled for adult use.
Annexe 3Unscheduled for adult use.
Unscheduled for adult use.
Unscheduled for adult use.
Unscheduled for adult use.
Unscheduled for adult use.
Desloratadine 5 mg
AERIUS®
NWT (Follows Napra National)
BC Alberta Manitoba (Follows Napra National)
Saskatchewan (Follows Napra National)
Ontario (Follows Napra National)
Quebec New Brunswick (Follows Napra National)
PEI (Follows Napra National)
Nova Scotia (Follows Napra National)
Nfld Yukon (Follows Napra National)
Product Catalog
Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montréal (QC), Canada H4P 2T4 6
Reactine is a registered trademark of Pfizer
Strength DIN/NPN Format National Brand Reference Shelf Life
10 mg 02315955Blistered 20 count Blistered 30 count
24 Months
Medicinal Ingredient Non-Medicinal Ingredients
ACTIVE INGREDIENTS: Each tablet contains:
10 mg of Cetirizine Hydrochloride.
Corn Starch, Hydroxypropyl Methylcellulose, Lactose, Magnesium Stearate,
Polyethylene Glycol, Povidone, Titanium Dioxide
Unscheduled in concentrations of 10 mg equivalent to 8.5 mg or
less of cetirizine base per dosage unit in products marketed for adult use.
Unscheduled for adult use.
Unscheduled in concentrations of 10 mg equivalent to 8.5 mg or
less of cetirizine base per dosage unit in products marketed for adult use.
Unscheduled in concentrations of 10 mg equivalent to 8.5 mg or
less of cetirizine base per dosage unit in products marketed for adult use.
Unscheduled in concentrations of 10 mg equivalent to 8.5 mg or
less of cetirizine base per dosage unit in products marketed for adult use.
Unscheduled in concentrations of 10 mg equivalent to 8.5 mg or
less of cetirizine base per dosage unit in products marketed for adult use.
Annexe 3
Unscheduled in concentrations of 10 mg equivalent to 8.5 mg or
less of cetirizine base per dosage unit in products marketed for adult use.
Unscheduled in concentrations of 10 mg equivalent to 8.5 mg or
less of cetirizine base per dosage unit in products marketed for adult use.
Unscheduled in concentrations of 10 mg equivalent to 8.5 mg or
less of cetirizine base per dosage unit in products marketed for adult use.
Unscheduled in concentrations of 10 mg equivalent to 8.5 mg or
less of cetirizine base per dosage unit in products marketed for adult use.
Unscheduled in concentrations of 10 mg equivalent to 8.5 mg or
less of cetirizine base per dosage unit in products marketed for adult use.
Cetirizine Hydrochloride 10 mg
REACTINE®
NWT (Follows Napra National)
BC Alberta Manitoba (Follows Napra National)
Saskatchewan (Follows Napra National)
Ontario (Follows Napra National)
Quebec New Brunswick (Follows Napra National)
PEI (Follows Napra National)
Nova Scotia (Follows Napra National)
Nfld Yukon (Follows Napra National)
Product Catalog
Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montréal (QC), Canada H4P 2T4 7
Aspirin is a registered trademark of Bayer
Strength DIN/NPN Format National Brand Reference Shelf Life
81 mg 02244993Bottled 30 count Bottled 120 countBottled 180 count
36 Months
Medicinal Ingredient Non-Medicinal Ingredients
ACTIVE INGREDIENTS: Each tablet contains:
Acetylsalicylic acid 81 mg.
Colloidal Silicon Dioxide, Lactose Anhydrous, Methacrylic Acid Copolymer Type C, Methylated Silica, Methylcellulose, Polydimethylsiloxane, Polyethylene Glycol,
Pregelatinized Starch, Purified Water, Sodium Bicarbonate, Sodium Lauryl Sulphate, Sorbitan Tristearate, Stearic Acid, Talc, Titanium Dioxide, Triethyl Citrate
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
Unscheduled (over 80 mg)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
Annexe 3 for over 30 tabs, hors annexe 30 or less
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
ASA 81mg EC
ASPIRIN®
NWT (Follows Napra National)
BC Alberta Manitoba (Follows Napra National)
Saskatchewan (Follows Napra National)
Ontario (Follows Napra National)
Quebec New Brunswick (Follows Napra National)
PEI (Follows Napra National)
Nova Scotia (Follows Napra National)
Nfld Yukon (Follows Napra National)
Product Catalog
Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montréal (QC), Canada H4P 2T4 8
Aspirin is a registered trademark of Bayer
Strength DIN/NPN Format National Brand Reference Shelf Life
81 mg 02304651Bottled 120 countBottled 180 count
36 Months
Medicinal Ingredient Non-Medicinal Ingredients
ACTIVE INGREDIENTS: Each tablet contains:
Acetylsalicylic acid 81mg.
D&C Yellow No. 10, FD&C Red No. 40, Mannitol, Orange Flavour, Pregelatinized Starch, Sodium Saccharin, Stearic Acid
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
Unscheduled (over 80 mg)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
Annexe 3 for over 30 tabs, hors annexe 30 or less
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
III (in products intended for oral adult use in
strengths of 81 mg per dosage unit and 650 mg
or greater per dosage unit, and in rectal preparations containing more than 150
mg per dosage unit)
ASA 81mg Chew
ASPIRIN®
NWT (Follows Napra National)
BC Alberta Manitoba (Follows Napra National)
Saskatchewan (Follows Napra National)
Ontario (Follows Napra National)
Quebec New Brunswick (Follows Napra National)
PEI (Follows Napra National)
Nova Scotia (Follows Napra National)
Nfld Yukon (Follows Napra National)
Product Catalog
Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montréal (QC), Canada H4P 2T4 9
Advil is a registered trademark of Pfizer
Strength DIN/NPN Format National Brand Reference Shelf Life
200 mg 02314762Bottled 30 countBottled 60 count Bottled 120 count
48 Months
Medicinal Ingredient Non-Medicinal Ingredients
ACTIVE INGREDIENTS: Each tablet contains: 200 mg of Ibuprofen.
Colloidal Sillicon Dioxide, Corn Starch, Dextrose Monohydrate, Hypromellose, Iron Oxide Red, Lactose Monohydrate, Lecithin, Maltodextrin, Povidone,
Pregelatinized Starch, Sodium Carboxymethylcellulose, Sodium Starch Glycolate, Stearic Acid, Titanium Dioxide, Triacetin
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Annexe 3 (less than 400mg)
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen 200 mg
ADVIL®
NWT (Follows Napra National)
BC Alberta Manitoba (Follows Napra National)
Saskatchewan (Follows Napra National)
Ontario (Follows Napra National)
Quebec New Brunswick (Follows Napra National)
PEI (Follows Napra National)
Nova Scotia (Follows Napra National)
Nfld Yukon (Follows Napra National)
Product Catalog
Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montréal (QC), Canada H4P 2T4 10
Advil is a registered trademark of Pfizer
Strength DIN/NPN Format National Brand Reference Shelf Life
400 mg 02314770Bottled 32 countBottled 72 count
48 Months
Medicinal Ingredient Non-Medicinal Ingredients
ACTIVE INGREDIENTS: Each tablet contains: 400 mg of Ibuprofen.
Colloidal Sillicon Dioxide, Corn Starch, Dextrose Monohydrate, Hypromellose, Iron Oxide Red, Lactose Monohydrate, Lecithin, Maltodextrin, Povidone,
Pregelatinized Starch, Sodium Carboxymethylcellulose, Sodium Starch Glycolate, Stearic Acid, Titanium Dioxide, Triacetin
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Annexe 2
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in
package sizes of up to 18,000 mg) Unscheduled
Ibuprofen and its salts containing 400 mg or less per oral dosage unit (when sold in package sizes exceeding
18,000 mg) Schedule
Ibuprofen 400 mg
ADVIL®
NWT (Follows Napra National)
BC Alberta Manitoba (Follows Napra National)
Saskatchewan (Follows Napra National)
Ontario (Follows Napra National)
Quebec New Brunswick (Follows Napra National)
PEI (Follows Napra National)
Nova Scotia (Follows Napra National)
Nfld Yukon (Follows Napra National)
Product Catalog
Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montréal (QC), Canada H4P 2T4 11
Colace is a registered trademark of Wellspring Pharmaceutical Canada corporation
Strength DIN/NPN Format National Brand Reference Shelf Life
100 mg 02281031 Bottled 100 count 24 Months
Medicinal Ingredient Non-Medicinal Ingredients
ACTIVE INGREDIENTS: Each capsule contains:
100 mg of Docusate Sodium.
FD&C Red No. 40, FD&C Yellow No. 6, Gelatin, Glycerin, Polyethylene Glycol, Propylene Glycol, Sodium methylparaben, sodium Propylparaben, Purified Water, Sorbitol.
Unscheduled Unscheduled Unscheduled Unscheduled Unscheduled Unscheduled
Unscheduled Unscheduled Unscheduled. Unscheduled Unscheduled Unscheduled
Docusate Sodium 100 mg
COLACE®
NWT (Follows Napra National)
BC Alberta Manitoba (Follows Napra National)
Saskatchewan (Follows Napra National)
Ontario (Follows Napra National)
Quebec New Brunswick (Follows Napra National)
PEI (Follows Napra National)
Nova Scotia (Follows Napra National)
Nfld Yukon (Follows Napra National)